Urate oxidase in the prophylaxis or treatment of hyperuricemia: The United States experience

Ablin, 1972, Nephropathy, xanthinuria, and orotic aciduria complicating Burkitt's lymphoma treated with chemotherapy and allopurinol, Metabolism, 21, 771, 10.1016/0026-0495(72)90124-2 Andreoli, 1986, Purine excretion during tumor lysis in children with acute lymphocytic leukemia receiving allopurinol: Relationship to acute renal failure, J Pediatr, 109, 292, 10.1016/S0022-3476(86)80387-0 Band, 1970, Xanthine nephropathy in a patient with lymphosarcoma treated with allopurinol, N Engl J Med, 283, 354, 10.1056/NEJM197008132830708 Berthemy, 1999, Quantitative determination of an extremely polar compound allantoin in human urine by LC-MS/MS based on the separation on a polymeric amino column, J Pharm Biomed Anal, 19, 429, 10.1016/S0731-7085(98)00200-3 Brogard, 1972, Enzymatic uricolysis: A study of the effect of a fungal urate-oxydase, Rev Eur Etudes Clin Biol, 17, 890 Choukair, 1996, Blood chemistries/body fluids, 119 Cohen, 1980, Acute tumor lysis syndrome: A review of 37 patients with Burkitt's lymphoma, Am J Med, 68, 486, 10.1016/0002-9343(80)90286-7 DeConti, 1966, Use of allopurinol for prevention and control of hyperuricemia in patients with neoplastic disease, N Engl J Med, 274, 481, 10.1056/NEJM196603032740902 Goldman, 2001, A randomized comparison between rasburicase and allopurinol in children with lymphoma or leukemia at high risk for tumor lysis, Blood, 97, 2998, 10.1182/blood.V97.10.2998 Greene, 1969, Urinary xanthine stones—A rare complication of allopurinol therapy, N Engl J Med, 280, 426, 10.1056/NEJM196902202800806 Holland, 1968, Prevention and management of acute hyperuricemia in childhood leukemia, J Pediatr, 72, 358, 10.1016/S0022-3476(68)80209-4 Jones, 1995, Tumor lysis syndrome: Pathogenesis and management, Pediatr Nephrol, 9, 206, 10.1007/BF00860751 Jones, 1990, Renal dysfunction and hyperuricemia at presentation and relapse of acute lymphoblastic leukemia, Med Pediatr Oncol, 18, 283, 10.1002/mpo.2950180405 Klinenberg, 1965, The effectiveness of the xanthine oxidase inhibitor allopurinol in the treatment of gout, Ann Intern Med, 62, 639, 10.7326/0003-4819-62-4-639 Krakoff, 1968, Hyperuricemia in neoplastic disease in children: Prevention with allopurinol, a xanthine oxidase inhibitor, Pediatrics, 41, 52, 10.1542/peds.41.1.52 Mahmoud, 1998, Advances in the management of malignancy-associated hyperuricaemia, Br J Cancer, 77, 18, 10.1038/bjc.1998.432 Masera, 1982, Urate-oxidase prophylaxis of uric acid-induced renal damage in childhood leukemia, J Pediatr, 100, 152, 10.1016/S0022-3476(82)80259-X Pui, 2000, Recombinant urate oxidase (rasburicase) in the prevention and treatment of malignancyassociated hyperuricemia: The compassionate use experience, Blood, 96, 719a Pui, 2001, Recombinant urate oxidase for the prophylaxis or treatment of hyperuricemia in patients with leukemia or lymphoma, J Clin Oncol, 19, 697, 10.1200/JCO.2001.19.3.697 Pui, 1997, Urate oxidase in prevention and treatment of hyperuricemia associated with lymphoid malignancies, Leukemia, 11, 1813, 10.1038/sj.leu.2400850 Rieselbach, 1964, Uric acid excretion and renal function in the acute hyperuricemia of leukemia: Pathogenesis and therapy of uric acid nephropathy, Am J Med, 37, 872, 10.1016/0002-9343(64)90130-5 Shohet, 1980, Acute renal failure complicating Burkitt's lymphoma treated with chemotherapy and allopurinol, Int J Pediatr Nephrol, 1, 240 Yeldandi, 1991, Molecular evolution of the urate oxidase-encoding gene in hominoid primates: Nonsense mutations, Gene, 109, 281, 10.1016/0378-1119(91)90622-I